Medical Microinstruments (MMI) announced on Nov. 20, 2026 the European launch of NanoWrist Monopolar Scissors, a new energy-enabled instrument for its Symani Surgical System. The scissors received CE Mark approval in October 2026 and are now available to hospitals across Europe, giving the robot its first tool that combines cutting with electrocautery in microsurgery.
MMI describes the instrument as the first fully articulated robotic electrosurgical tool built for open microsurgery, letting surgeons perform sharp and blunt dissection plus cutting and coagulation of soft tissue with a single device instead of swapping instruments mid-procedure. Early clinical use includes lymphovenous bypass surgery for breast-cancer-related lymphedema at Bellvitge Hospital in Spain and head-and-neck cancer resection at RWTH Aachen University in Germany. CEO Mark Toland said adding energy to Symani "not only puts more power in surgeons' hands but changes the way to think about energy instruments in microsurgery," according to GlobeNewswire.
Why cautery changes the calculus for microsurgery robots
Symani is built around the smallest wristed microinstruments on the market, aimed at procedures too fine for standard surgical robots, such as repairing lymphatic vessels as narrow as 0.2mm. Until now, a surgeon using Symani for dissection who needed to stop bleeding had to pause and reach for a separate energy device, often a non-robotic one, breaking the workflow the robot is supposed to streamline. A single wristed instrument that both cuts and cauterizes removes that handoff, which matters most in procedures like lymphatic surgery where vessels are too delicate for anything but precise, low-trauma energy delivery.
Pisa, Italy-based MMI founded the company in 2015 specifically around supermicrosurgery, a niche adjacent to but distinct from the broader robotic surgery market dominated by Intuitive Surgical's da Vinci platform. Intuitive and most general-purpose surgical robots are not built for vessel repair at sub-millimeter scale, which has left MMI largely uncontested in that specific lane rather than competing head-on for operating-room budgets.
What's still missing: US clearance
The NanoWrist Monopolar Scissors are CE-marked but not yet FDA-cleared; an application is pending, and the instrument cannot be sold in the United States until it clears that review. That gap means European hospitals get the energy-enabled tool roughly a generation ahead of their American counterparts, mirroring a pattern common in surgical robotics where CE marking under the EU's more streamlined pathway often arrives before FDA 510(k) clearance.
For MMI, the timing matters because Symani itself is already both FDA-authorized and CE-marked, meaning the base platform has a foothold in both markets. Whether the company can convert European energy-instrument data into a faster FDA review will likely determine how quickly US microsurgery programs, which have been adopting Symani for reconstructive and lymphedema procedures, get access to the same combined dissection-and-cautery workflow now rolling out across Spain and Germany.